-
公开(公告)号：US10398715B2
公开(公告)日：2019-09-03
申请号：US14428247
申请日：2013-09-12
Applicant: ABBOTT LABORATORIES
Inventor： Enrique Vazquez Hernandez , Ricardo Rueda Cabrera , Rachael Buck , Maria Ramirez Gonzalez , Alejandro Barranco Perez
IPC: A61K31/702 , A61K31/7016 , A23L33/00 , A23L33/10 , A23L1/29
Abstract: Disclosed are methods for enhancing learning and/or memory, enhancing memory acquisition, memory retention and recall by inducing a higher long-term potentiation in hippocampal neuronal synapsis in individuals. The methods include administration of 2-fucosyl-lactose to an individual.
-
公开(公告)号：US20180008623A1
公开(公告)日：2018-01-11
申请号：US15707477
申请日：2017-09-18
Applicant: ABBOTT LABORATORIES
Inventor： Rachael Buck , Debra Thomas , Joseph Schaller
IPC: A61K31/702 , A61K31/7068 , A61K31/708 , A61K31/7072 , A61K31/7076
Abstract: Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
-
公开(公告)号：US12280069B2
公开(公告)日：2025-04-22
申请号：US17562327
申请日：2021-12-27
Applicant: ABBOTT LABORATORIES
Inventor： Rachael Buck , Geralyn O. Duska-Mcewen , Steven R. Davis
IPC: A61K31/702 , A23C9/20 , A23L33/00 , A61K31/05 , A61K31/716
Abstract: Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for improving airway defense mechanisms.
-
公开(公告)号：US11998577B2
公开(公告)日：2024-06-04
申请号：US17682051
申请日：2022-02-28
Applicant: ABBOTT LABORATORIES
Inventor： Alejandro Barranco Perez , Maria Ramirez Gonzalez , Rachael Buck , Enrique Vazquez Hernandez
IPC: A61K35/747 , A23L33/00 , A23L33/125 , A23L33/135 , A23L33/15 , A61K9/107 , A61K31/015 , A61K31/047 , A61K31/07 , A61K31/122 , A61K31/14 , A61K31/145 , A61K31/205 , A61K31/355 , A61K31/405 , A61K31/4188 , A61K31/4415 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/702 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61K31/714 , A61K33/06 , A61K33/26 , A61K33/30 , A61K35/20 , A61K35/745 , A61K47/02 , A61K47/12 , A61K47/14 , A61K47/22 , A61K47/24 , A61K47/26 , A61K47/36 , A61K47/42 , A61K47/44 , A61K47/46 , A61P1/14
CPC classification number: A61K35/747 , A23L33/125 , A23L33/135 , A23L33/15 , A23L33/40 , A61K9/107 , A61K31/015 , A61K31/047 , A61K31/07 , A61K31/122 , A61K31/14 , A61K31/145 , A61K31/205 , A61K31/355 , A61K31/405 , A61K31/4188 , A61K31/4415 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/702 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61K31/714 , A61K33/06 , A61K33/26 , A61K33/30 , A61K35/20 , A61K35/745 , A61K47/02 , A61K47/12 , A61K47/14 , A61K47/22 , A61K47/24 , A61K47/26 , A61K47/36 , A61K47/42 , A61K47/44 , A61K47/46 , A61P1/14 , A23V2002/00
Abstract: Disclosed are nutritional compositions including 2′-fucosyllactose (2′-FL) in combination with lutein and RRR-alpha-tocopherol. The nutritional compositions are useful for improving at least one of gut function, health, and development in an individual. In certain embodiments, the nutritional compositions can improve growth or maturation of the gut, as well as promote a healthy balance of beneficial bacteria in the gastrointestinal tract thereby treating and/or preventing formula intolerance or other gastrointestinal diseases and/or disorders resulting from suboptimal gastrointestinal flora population/balance.
-
15.发明公开公开(公告)号：US20230338404A1
公开(公告)日：2023-10-26
申请号：US18345357
申请日：2023-06-30
Applicant: ABBOTT LABORATORIES
Inventor： JoMay Chow , Steven R. Davis , Rachael Buck , Geralyn O. Duska-McEwen , Hawley K. Linke
IPC: A61K31/702 , A23L33/00 , A61K31/716 , A61K45/06 , A23L33/10 , A23L33/12 , A23L33/19 , A23L33/135 , A61K9/107 , A61K31/733 , A61K35/20 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/48 , A61K38/01
CPC classification number: A61K31/702 , A23L33/40 , A61K31/716 , A61K45/06 , A23L33/10 , A23L33/12 , A23L33/19 , A23L33/30 , A23L33/135 , A61K9/107 , A61K31/733 , A61K35/20 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/48 , A61K38/018 , A23V2002/00 , A61K2035/115
Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
-
Patent Agency Ranking
公开(公告)号：US11690859B2
公开(公告)日：2023-07-04
申请号：US16698422
申请日：2019-11-27
Applicant: ABBOTT LABORATORIES
Inventor： JoMay Chow , Steven R. Davis , Rachael Buck , Geralyn O. Duska-McEwen , Hawley K. Linke
IPC: A61K31/70 , A01N43/04 , A61K31/702 , A23L33/00 , A61K31/716 , A61K45/06 , A23L33/10 , A23L33/12 , A23L33/19 , A23L33/135 , A61K9/107 , A61K31/733 , A61K35/20 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/48 , A61K38/01 , A61K35/00
CPC classification number: A61K31/702 , A23L33/10 , A23L33/12 , A23L33/135 , A23L33/19 , A23L33/30 , A23L33/40 , A61K9/107 , A61K31/716 , A61K31/733 , A61K35/20 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/48 , A61K38/018 , A61K45/06 , A23V2002/00 , A61K2035/11 , A61K2035/115 , A61K31/702 , A61K2300/00 , A61K31/716 , A61K2300/00 , A23V2002/00 , A23V2200/32 , A23V2250/282
Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
-
17.发明授权公开(公告)号：US11633412B2
公开(公告)日：2023-04-25
申请号：US15892234
申请日：2018-02-08
Applicant: ABBOTT LABORATORIES
Inventor： Rachael Buck , Geralyn O. Duska-McEwen , Joseph P. Schaller
IPC: A61K31/702 , A23L33/00 , A23L33/12 , A61K31/202 , A61K31/7016 , A61K45/06
Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
-
公开(公告)号：US20210038620A1
公开(公告)日：2021-02-11
申请号：US17078239
申请日：2020-10-23
Applicant: ABBOTT LABORATORIES
Inventor： Rachael Buck , Debra Thomas , Joseph Schaller
IPC: A61K31/702 , A23L33/00 , A23L33/13 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61P1/12 , A23L33/125 , A61P31/12
Abstract: Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
-
19.发明申请公开(公告)号：US20200093846A1
公开(公告)日：2020-03-26
申请号：US16698422
申请日：2019-11-27
Applicant: ABBOTT LABORATORIES
Inventor： JoMay Chow , Steven R. Davis , Rachael Buck , Geralyn O. Duska-McEwen , Hawley K. Linke
IPC: A61K31/702 , A61K45/06 , A61K38/01 , A61K35/744 , A23L33/00 , A61K31/733 , A61K35/20 , A23L33/10 , A23L33/12 , A61K31/716 , A23L33/19 , A61K36/48 , A61K35/747 , A61K9/107 , A61K35/745 , A23L33/135
Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
-
公开(公告)号：US10398716B2
公开(公告)日：2019-09-03
申请号：US14428260
申请日：2013-09-12
Applicant: ABBOTT LABORATORIES
IPC: A61K31/702 , A61K9/00 , A23L33/00 , A23L33/21
Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
-
-
-
-
-
-
-
-
-
Search Results
39
records
(took 0.029 seconds)
